HIGHLIGHTS
-
Neuropathic pain is caused by a lesion that affects the somatosensory system.
-
Neuropathic pain affects about 10% of the population.
-
Neuropathic pain can impact patients’ quality of life and functionality.
-
The lidocaine patch produced analgesia in the cases studied, with long-term safety and tolerability.
ABSTRACT
BACKGROUND AND OBJECTIVES:
Post-surgical neuropathic pain (NP) is an important clinic condition, with recurring pain and that may be a result of transection, contusion, nerve inflammation or stretching and lasting for 3-6 months. Having into consideration the prevalence of postoperative localized NP, its impact in quality of life of patients, its complexity of diagnosis and treatment and available treatment options, the aim of this report was to present efficacy, safety and tolerability outcomes of 5% lidocaine transdermal patch use as a single treatment or in combination with other therapeutic options by describing and analyzing four clinical cases.
CASES REPORT:
Four patients aged between 43 and 70 years old and complains of postoperative localized NP were managed with 5% lidocaine transdermal patch in prolonged treatment, with significant improvement in pain scores.
CONCLUSION:
The outcomes of the described cases revealed that postoperative localized NP management was successful with 5% lidocaine transdermal patch. Moreover, it was possible to observe that its association to other treatments (pharmacological or not) has proved efficacy with no negative impact the tolerability of the treatment or the patient routine and comfort.
Keywords
Case-control studies; Nerve compression; Pain; Peripheral nervous system disease; Postoperative; Transdermal patch